Cargando…

Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder

Background   Gastroparesis is a common gastrointestinal pathology that has been increasing in prevalence and represents a significant cost to the United States healthcare system. Gastroparesis is associated with psychological dysfunction, including generalized anxiety disorder (GAD). GAD is known to...

Descripción completa

Detalles Bibliográficos
Autores principales: Mathew, Anna G, Kaye, Alexander J, Patel, Shivani J, Meyers, Sarah R, Saiganesh, Pooja, Wang, Weizheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075333/
https://www.ncbi.nlm.nih.gov/pubmed/37033595
http://dx.doi.org/10.7759/cureus.35832
_version_ 1785019902204051456
author Mathew, Anna G
Kaye, Alexander J
Patel, Shivani J
Meyers, Sarah R
Saiganesh, Pooja
Wang, Weizheng
author_facet Mathew, Anna G
Kaye, Alexander J
Patel, Shivani J
Meyers, Sarah R
Saiganesh, Pooja
Wang, Weizheng
author_sort Mathew, Anna G
collection PubMed
description Background   Gastroparesis is a common gastrointestinal pathology that has been increasing in prevalence and represents a significant cost to the United States healthcare system. Gastroparesis is associated with psychological dysfunction, including generalized anxiety disorder (GAD). GAD is known to be a prevalent and chronic manifestation of anxiety, which has been increasing in prevalence since the year 2020. Despite the association between gastroparesis and GAD, there has been limited research on the possible impact GAD may have on the morbidity and mortality of patients hospitalized for gastroparesis, which is further evaluated in this study.   Methods   Using the Nationwide Inpatient Sample from the year 2014, a retrospective study was conducted to assess the outcomes of hospitalized gastroparesis patients with and without a history of GAD. In this study, the analyzed outcomes included acute kidney injury (AKI), acute respiratory failure, sepsis, acute deep vein thrombosis, myocardial infarction, intestinal obstruction, and inpatient mortality. To assess whether GAD is an independent risk factor for the outcomes, a multivariate logistic regression analysis was used.   Results   There were 22,150 patients with gastroparesis assessed in this study; GAD was found to be a comorbid diagnosis in 4,196 of those patients. In the GAD cohort, there was an elevated risk for AKI (adjusted odds ratio 1.24, p < 0.001). The adjusted odds ratios for acute respiratory failure, sepsis, acute deep vein thrombosis, myocardial infarction, intestinal obstruction, and inpatient mortality did not meet the threshold for statistical significance.   Conclusion   In hospitalized gastroparesis patients, GAD is a risk factor for AKI. This finding may be attributed to prerenal azotemia due to an increased risk of nausea and vomiting associated with GAD, as well as the medications used to treat GAD such as escitalopram and duloxetine. In addition, the dual inflammatory states caused by the co-existence of both GAD and gastroparesis may also have a role in increasing the risk for AKI. The results of this study may become increasingly relevant given the increasing prevalence of GAD.  
format Online
Article
Text
id pubmed-10075333
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-100753332023-04-06 Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder Mathew, Anna G Kaye, Alexander J Patel, Shivani J Meyers, Sarah R Saiganesh, Pooja Wang, Weizheng Cureus Internal Medicine Background   Gastroparesis is a common gastrointestinal pathology that has been increasing in prevalence and represents a significant cost to the United States healthcare system. Gastroparesis is associated with psychological dysfunction, including generalized anxiety disorder (GAD). GAD is known to be a prevalent and chronic manifestation of anxiety, which has been increasing in prevalence since the year 2020. Despite the association between gastroparesis and GAD, there has been limited research on the possible impact GAD may have on the morbidity and mortality of patients hospitalized for gastroparesis, which is further evaluated in this study.   Methods   Using the Nationwide Inpatient Sample from the year 2014, a retrospective study was conducted to assess the outcomes of hospitalized gastroparesis patients with and without a history of GAD. In this study, the analyzed outcomes included acute kidney injury (AKI), acute respiratory failure, sepsis, acute deep vein thrombosis, myocardial infarction, intestinal obstruction, and inpatient mortality. To assess whether GAD is an independent risk factor for the outcomes, a multivariate logistic regression analysis was used.   Results   There were 22,150 patients with gastroparesis assessed in this study; GAD was found to be a comorbid diagnosis in 4,196 of those patients. In the GAD cohort, there was an elevated risk for AKI (adjusted odds ratio 1.24, p < 0.001). The adjusted odds ratios for acute respiratory failure, sepsis, acute deep vein thrombosis, myocardial infarction, intestinal obstruction, and inpatient mortality did not meet the threshold for statistical significance.   Conclusion   In hospitalized gastroparesis patients, GAD is a risk factor for AKI. This finding may be attributed to prerenal azotemia due to an increased risk of nausea and vomiting associated with GAD, as well as the medications used to treat GAD such as escitalopram and duloxetine. In addition, the dual inflammatory states caused by the co-existence of both GAD and gastroparesis may also have a role in increasing the risk for AKI. The results of this study may become increasingly relevant given the increasing prevalence of GAD.   Cureus 2023-03-06 /pmc/articles/PMC10075333/ /pubmed/37033595 http://dx.doi.org/10.7759/cureus.35832 Text en Copyright © 2023, Mathew et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Internal Medicine
Mathew, Anna G
Kaye, Alexander J
Patel, Shivani J
Meyers, Sarah R
Saiganesh, Pooja
Wang, Weizheng
Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder
title Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder
title_full Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder
title_fullStr Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder
title_full_unstemmed Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder
title_short Outcomes of Gastroparesis in Hospitalized Patients With Generalized Anxiety Disorder
title_sort outcomes of gastroparesis in hospitalized patients with generalized anxiety disorder
topic Internal Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10075333/
https://www.ncbi.nlm.nih.gov/pubmed/37033595
http://dx.doi.org/10.7759/cureus.35832
work_keys_str_mv AT mathewannag outcomesofgastroparesisinhospitalizedpatientswithgeneralizedanxietydisorder
AT kayealexanderj outcomesofgastroparesisinhospitalizedpatientswithgeneralizedanxietydisorder
AT patelshivanij outcomesofgastroparesisinhospitalizedpatientswithgeneralizedanxietydisorder
AT meyerssarahr outcomesofgastroparesisinhospitalizedpatientswithgeneralizedanxietydisorder
AT saiganeshpooja outcomesofgastroparesisinhospitalizedpatientswithgeneralizedanxietydisorder
AT wangweizheng outcomesofgastroparesisinhospitalizedpatientswithgeneralizedanxietydisorder